Foresight Q2 2026 Results Highlight Going Concern Doubt and Nasdaq Delisting Risk
FRSX is trading near its 52-week low of $1.15 (13% above the low).
Summary
Foresight's Q2 2026 results come with a going concern warning and Nasdaq delisting risk, while the VisionWave investment remains dead after shareholder rejection.
Key Events · Earnings and Guidance · FRSX
-
Going Concern Warning
The financial statements include an explanatory paragraph raising substantial doubt about the Company's ability to continue as a going concern.
-
Nasdaq Delisting Risk
A new Nasdaq Listing Rule 5550(a)(6) requires a minimum MVLS of $5 million; the SEC stayed implementation on July 29, 2026, but the rule may become effective near-term.
-
Cash Runway
Existing cash of $7.1 million is expected to fund operations only through the end of April 2027.
-
VisionWave Deal Dead
Shareholders rejected the $17.5 million strategic investment from VisionWave on July 23, 2026; the transaction will not proceed.
Analysis · FRSX · Technology
The Q2 2026 financials reveal a net loss of $2.8 million on revenue of just $86,000, with cash of $7.1 million expected to last only until April 2027. A going concern warning is included in the financial statements, and the company flags a new Nasdaq rule that could trigger delisting if its market value stays below $5 million. With the VisionWave investment rejected, the company lacks a strategic backer and faces increased reliance on dilutive ATM sales.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FRSX was trading at $1.30 on NASDAQ in the Technology sector, with a market capitalization of approximately $7M. The 52-week trading range was $1.15 to $8.32. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.